BNP Paribas Financial Markets’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.7M Sell
400,765
-203,835
-34% -$24.7M 0.01% 848
2026
Q1
$98.9M Sell
604,600
-310,819
-34% -$47.8M 0.05% 410
2025
Q4
$159M Buy
915,419
+482,079
+111% +$88M 0.07% 252
2025
Q3
$62.4M Sell
433,340
-320,820
-43% -$39.3M 0.03% 536
2025
Q2
$75.9M Buy
754,160
+292,497
+63% +$22.4M 0.04% 413
2025
Q1
$35.2M Buy
461,663
+274,647
+147% +$21M 0.02% 767
2024
Q4
$12.9M Sell
187,016
-129,860
-41% -$9.35M 0.01% 1223
2024
Q3
$23.1M Buy
316,876
+255,268
+414% +$18.8M 0.02% 807
2024
Q2
$4.13M Sell
61,608
-178,376
-74% -$6.92M ﹤0.01% 1513
2024
Q1
$6.51M Buy
239,984
+18,412
+8% +$515K 0.01% 1288
2023
Q4
$6.87M Buy
221,572
+98,417
+80% +$2.55M 0.01% 1232
2023
Q3
$3.11M Buy
123,155
+27,020
+28% +$618K ﹤0.01% 1598
2023
Q2
$2.03M Sell
96,135
-283,460
-75% -$5.38M ﹤0.01% 1745
2023
Q1
$6.47M Sell
379,595
-150,626
-28% -$2.93M 0.01% 1110
2022
Q4
$10.6M Buy
+530,221
New +$10.2M 0.02% 955
2022
Q3
Sell
-33,133
Closed -$653K 4876
2022
Q2
$653K Sell
33,133
-42,779
-56% -$896K ﹤0.01% 2508
2022
Q1
$1.78M Buy
75,912
+4,718
+7% +$110K ﹤0.01% 1912
2021
Q4
$1.94M Buy
71,194
+49,639
+230% +$1.42M ﹤0.01% 2054
2021
Q3
$594K Sell
21,555
-15,671
-42% -$411K ﹤0.01% 2670
2021
Q2
$1.06M Buy
37,226
+24,331
+189% +$722K ﹤0.01% 2147
2021
Q1
$439K Sell
12,895
-2,298
-15% -$87.8K ﹤0.01% 2638
2020
Q4
$506K Sell
15,193
-8,648
-36% -$316K ﹤0.01% 2453
2020
Q3
$766K Buy
23,841
+12,368
+108% +$355K ﹤0.01% 1953
2020
Q2
$316K Sell
11,473
-33,485
-74% -$794K ﹤0.01% 2291
2020
Q1
$721K Buy
44,958
+32,219
+253% +$764K ﹤0.01% 2134
2019
Q4
$304K Sell
12,739
-2,993
-19% -$60.9K ﹤0.01% 2758
2019
Q3
$278K Buy
15,732
+5,419
+53% +$105K ﹤0.01% 2562
2019
Q2
$264K Sell
10,313
-34,634
-77% -$965K ﹤0.01% 2428
2019
Q1
$1.31M Buy
44,947
+43,110
+2,347% +$1.12M ﹤0.01% 1590
2018
Q4
$24.1K Sell
1,837
-2,556
-58% -$40.8K ﹤0.01% 3036
2018
Q3
$88.8K Buy
4,393
+120
+3% +$2.71K ﹤0.01% 2801
2018
Q2
$101K Sell
4,273
-11,970
-74% -$308K ﹤0.01% 2795
2018
Q1
$366K Buy
16,243
+60
+0.4% +$1.58K ﹤0.01% 2417
2017
Q4
$505K Buy
16,183
+7,818
+93% +$231K ﹤0.01% 2469
2017
Q3
$261K Buy
8,365
+867
+12% +$16.5K ﹤0.01% 2330
2017
Q2
$129K Buy
7,498
+6,520
+667% +$111K ﹤0.01% 2697
2017
Q1
$17.1K Sell
978
-666
-41% -$10.3K ﹤0.01% 3059
2016
Q4
$21.8K Sell
1,644
-3,009
-65% -$41K ﹤0.01% 3143
2016
Q3
$67.6K Buy
4,653
+2,245
+93% +$28.1K ﹤0.01% 2296
2016
Q2
$23.7K Buy
+2,408
New +$28.1K ﹤0.01% 2521
2016
Q1
Sell
-13,084
Closed -$237K 2868
2015
Q4
$237K Buy
13,084
+555
+4% +$9.78K ﹤0.01% 1822
2015
Q3
$233K Buy
12,529
+7,413
+145% +$185K ﹤0.01% 1851
2015
Q2
$125K Buy
5,116
+3,943
+336% +$89.5K ﹤0.01% 1970
2015
Q1
$24.4K Buy
+1,173
New +$20.7K ﹤0.01% 2281
2014
Q4
Sell
-3,136
Closed -$40.9K 2574
2014
Q3
$40.9K Buy
+3,136
New +$47.3K ﹤0.01% 2707
2014
Q2
Sell
-10
Closed -$139 3883
2014
Q1
$139 Sell
10
-439
-98% -$8.34K ﹤0.01% 3262
2013
Q4
$7.63K Buy
+449
New +$6.88K ﹤0.01% 2822
2013
Q3
Sell
-11,872
Closed -$142K 2641
2013
Q2
$142K Buy
+11,872
New +$121K ﹤0.01% 2459

Other funds holding INSM

BNP Paribas Financial Markets's INSM Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Insmed (INSM) stake by 34% in Q2 2026, selling an estimated $24.7M and leaving 400,765 shares worth $42.7M. The position accounts for 0.01% of the portfolio, ranked #848.

BNP Paribas Financial Markets first reported a position in INSM in Q2 2013 and has held it in 48 quarters since. The position peaked at $159M in Q4 2025. 456 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • BNP Paribas Financial Markets held 400,765 shares of Insmed worth $42.7M as of Q2 2026.
  • BNP Paribas Financial Markets sold 203,835 Insmed shares in Q2 2026, an estimated $24.7M.
  • Insmed made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #848 holding.
  • BNP Paribas Financial Markets first reported a position in Insmed in Q2 2013 and has held it in 48 quarters since.
  • BNP Paribas Financial Markets's Insmed position peaked at $159M in Q4 2025.
  • 456 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.